Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.DSP Completes Acquisition Of Sepracor
Dainippon Sumitomo Pharma (DSP) and Sepracor (Sepracor) have announced the successful completion of DSP’s acquisition of Sepracor for $23 per share in cash. DSP completed the acquisition through
Dainippon Sumitomo Pharma (DSP) and Sepracor (Sepracor) have announced the successful completion of DSP’s acquisition of Sepracor for $23 per share in cash. DSP completed the acquisition through
Pfizer has reported revenues of $11.6b for the third-quarter of 2009, a 3% decrease compared with $12b in the year-ago quarter. Revenues for the quarter compared with the
Pharmaco Group is extending its production line with six new drugs, which belong both to already existent and new therapeutic groups. Reportedly, Domestic pharmaceutical company keeps on developing
Genzyme has begun enrollment in the first of two global, multi-center, phase 3 trials of Genz-112638, a new oral therapy for Gaucher disease type 1. Reportedly, the two
XOMA has announced the presentation of peer-reviewed results with XOMA 052, its antibody to interleukin-1 beta (IL-1 beta), at two international conferences. Preclinical results with XOMA 052 in
MediWound has reported positive results from a pre planned interim analysis of a phase III trial for Debrase, an enzymatic debriding agent for burns. The company reported that
Novavax (Novavax) has initiated two-stage clinical study of its virus-like-particle (VLP) H1N1 influenza vaccine in Mexico in collaboration with Avimex Laboratories (Avimex) and GE Healthcare. Avimex is providing
Bristol-Myers Squibb has reported that new clinical data support continued development of a subcutaneous administration of Orencia (abatacept) for patients with moderate to severe rheumatoid arthritis. Reportedly, the
Freeman Technology and Harro Hofliger will present Freeman Technology FT4 Powder Rheometer at the 2009 AAPS Annual Meeting and Exposition Angeles, US. The collaborative work between Freeman Technology
Mylan has announced that two of its subsidiaries have resolved a longstanding dispute with the US Department of Justice relating to certain Medicaid rebate classifications. Mylan’s subsidiaries Mylan